TAFINLAR (dabrafenib mesylate)
ANTINEOPLASTIC - BRAF KINASE INHIBITORS · MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+5
Novartis Pharmaceuticals
All drugs.
Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.
Enter at least 3 characters to search the full directory.
Results
BRAFTOVI (encorafenib)
ORAL TREATMENTS FOR NON-SMALL CELL LUNG CANCER · MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+3
ARRAY/PFIZER
OJEMDA (tovorafenib)
ANTINEOPLASTIC - BRAF KINASE INHIBITORS · LOW GRADE GLIOMA WITH BRAF FUSION OR MUTATION
DAY ONE BIOPHAR
OJEMDA (tovorafenib)
ANTINEOPLASTIC - BRAF KINASE INHIBITORS · LOW GRADE GLIOMA WITH BRAF FUSION OR MUTATION
DAY ONE BIOPHAR
TAFINLAR (dabrafenib mesylate)
ANTINEOPLASTIC - BRAF KINASE INHIBITORS · MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+5
Novartis Pharmaceuticals